CMS Innovation Models

Synthesis:

In the past 24 hours, CMS finalized its 2027 Medicare Advantage (MA) payment update, triggering immediate market reactions as UnitedHealth, Humana, CVS, and Oscar Health stocks all rose sharply, reflecting relief that anticipated rate cuts did not materialize and that MA payment growth will continue to support value-based care initiatives. Meanwhile, CMS continues to leverage policy shifts—including expanded use of AI—to reshape operating models and deepen partnerships in value-based care, as seen in Innovaccer’s rapid integration of CMS-backed AI tools to bolster ACO and population health capabilities. At the same time, regulatory tensions persist, highlighted by CMS's threat to block enrollment in certain Medicare drug plans, reinforcing the importance of compliant, efficient model governance as the agency prioritizes accountable performance in new alternative payment models. Sources: [Oscar Health stock rises after CMS finalizes 2027 Medicare Advantage payment update](https://news.google.com/rss/articles/CBMigANBVV95cUxPR2RDcXFMaGFuSjBBZ0xENElHWmZPaTR0bWZnVktJc2VZU3pUODNSS0JUdHpNZFk0RVFpLWNYVlRmQnBXOFE0MzRMNzVRRktyX05NeUtNVjZVYUpsM2RyWUtjdGF6azBYQVRfTDFDV0dtY25wWnB6MUVRWkd